Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
06/2005
06/30/2005CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof
06/30/2005CA2549603A1 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them
06/30/2005CA2549598A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
06/30/2005CA2549167A1 Inhibitors of hepatitis c virus ns3/ns4a serine protease
06/30/2005CA2548388A1 Heterocyclic aspartyl protease inhibitors
06/30/2005CA2548273A1 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
06/30/2005CA2547518A1 Quinolines useful in treating cardiovascular disease
06/30/2005CA2545767A1 Novel compounds which are modulators of the ppar-type receptors and their use in cosmetic or pharmaceutical compositions
06/30/2005CA2545294A1 Tetronic and tetramic acids as inhibitors of beta-secrease
06/29/2005EP1548007A1 2-Pyridinylethylcarboxamide derivatives and their use as fungicides
06/29/2005EP1548005A1 Process for producing 2-substituted pyridine derivative
06/29/2005EP1546158A1 Azole derivatives as antifungal agents
06/29/2005EP1546144A2 Delta1 pyrrolines used as pesticides
06/29/2005EP1546143A1 Heterocyclic substituted piperazines for the treatment of schizophrenia
06/29/2005EP1546137A1 Benzimidazol-1-yl-thiophene compounds for the treatment of cancer
06/29/2005EP1546128A1 Pyrimidine derivatives as selective cox-2 inhibitors
06/29/2005EP1546117A2 Protein kinase inhibitors and uses thereof
06/29/2005EP1546116A1 Vanilloid receptor ligands and their use in treatments
06/29/2005EP1546109A2 Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)
06/29/2005EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation
06/29/2005EP1545543A2 Novel tyrosine kinases inhibitors
06/29/2005EP1545528A2 Indole-type derivatives as inhibitors of p38 kinase
06/29/2005EP1545523A1 3-&-grave;(HETERO) ARYLMETHOXY ! PYRIDINES AND THEIR ANALOGUES ASP38 MAP KINASE INHIBITORS
06/29/2005EP1487826A4 NEW CRYSTALLINE FORMS OF (2S)-N-5-(AMINO(IMINO)METHYL)-2-THIENYLMETHYL-1-(2R)-2-((CARBOXYMETHYL)AMINO)-3,3-DIPHENYLPROPANOYL-2-PYRROLIDINECARBOXAMIDE.nH2O
06/29/2005EP1274701B1 [1,4']-bipiperidine compounds
06/29/2005CN1633433A N-aroyl cyclic amines
06/29/2005CN1633429A 1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
06/29/2005CN1633428A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
06/29/2005CN1633419A CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
06/29/2005CN1633418A Arylalkane-sulfonamides having endothelin-antagonist activity
06/29/2005CN1633416A Nicotinamide derivates useful as p38 inhibitors
06/29/2005CN1633414A Chemical compounds
06/29/2005CN1633410A Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps)
06/29/2005CN1633403A Process for the production of 1, 2-dichloroethane by direct chlorination
06/29/2005CN1208322C Dihydroindole and tetrahydroquinoline derivatives
06/29/2005CN1208321C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
06/29/2005CN1208319C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
06/29/2005CN1208318C Cycloamine CCR5 receptor antagonists
06/28/2005US6911549 Method of preparing a taxol derivative
06/28/2005US6911469 For therapy of disease treatable based on a blood sugar level-depressing activity or a disease treatable based on a cGMP-PDE inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity
06/28/2005US6911465 For treating inflammatory diseases including rheumatoid arthritis, glomerular nephritides, lung fibrosis, restenosis, alveolitis, asthma, psoriasis, inflammatory bowel disease, multiple sclerosis and brain trauma, stroke, ischemia
06/28/2005US6911463 Capable of increasing lipolysis and energy expenditure in cells and therefore is useful for treating Type 2 diabetes and/or obesity
06/28/2005US6911462 Benzimidazole compounds for regulating IgE
06/28/2005US6911461 For treating epilepsy, epileptogenesis, seizure disorders, convulsions, bipolar disorders, mania, depression, anxiety, migraine, neuralgia, chronic pain, neuropathic pain, cerebral ischemia, cardiac arrhythmia, myotonia, cocaine abuse
06/28/2005US6911453 Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them
06/28/2005US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents
06/28/2005CA2159071C 4-arylisoindole analgesics
06/28/2005CA2114746C Substituted triazolinones
06/23/2005WO2005057207A1 Trityl derivatives for enhancing mass spectrometry
06/23/2005WO2005056549A1 Water-soluble etoposide analogs and methods of use thereof
06/23/2005WO2005056533A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
06/23/2005WO2005056528A1 Carboxamide derivatives
06/23/2005WO2005056508A1 Method for the production of tetrahydrogeranylacetone
06/23/2005WO2005056015A1 Substituted piperazines
06/23/2005WO2005055941A2 Novel m3 muscarinic acetylcholine receptor antagonists
06/23/2005WO2005042444A3 Platinum complex and luminescent element
06/23/2005WO2005037272A8 Benzimidazole derivatives and use thereof as peptide deformylase inhibitors
06/23/2005WO2005035488A3 Thiophene-2-carboxamide derivatives and use thereof as cannabinoid cb-1 receptor antagonists
06/23/2005WO2005034870A3 Amide compounds and ion channel ligands and uses thereof
06/23/2005WO2005025555A3 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid
06/23/2005WO2004052366A9 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists
06/23/2005US20050137399 A lithium-free reaction to produce a substituted/unsubstituted 4-amino-3-benzimidazol-2-yl-quinolin-2-one compound by reacting a 2-aminobenzonitrile with a 2-alkyloxycarbonylmethyl-benzimidazole in a solvent in the presence of a sodium or potassium salt of a base; excellent yields
06/23/2005US20050137395 E.g., 6-[(7-iodoquinolin-4-yl)oxy]-N,2-dimethyl-1-benzofuran-3-carboxamide; antiproliferative agent for hyperproliferative disorders being either cancerous or noncancerous; vasculogenesis or angiogenesis inhibitors; adminstered with hypotensive agent, antitumor agents, mitotic inhibitors and others
06/23/2005US20050137243 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
06/23/2005US20050137234 Histone deacetylase inhibitors
06/23/2005US20050137230 Factor Xa-inhibitors; preventing thromboembolic illnesses and tumors; 2-amino-N-(2'-methylsulfonylbiphenyl-4-yl)-3-phenylpropionamide
06/23/2005US20050137228 Benzyl sulfonamide derivatives
06/23/2005US20050137224 2-Cyanopyrrolidinecarboxamide compound
06/23/2005US20050137216 Heterocyclic sodium/proton exchange inhibitors and method
06/23/2005US20050137215 Antiarthritic and antiinflammatory agents; analgesics; the proline derivatives do not displace gabapentin from alpha-2-delta receptors
06/23/2005US20050137212 Hppars activators
06/23/2005US20050137196 Medical devices employing triazine compounds and compositions thereof
06/23/2005US20050137191 Nitrate esters and their use for mitigating cellular damage
06/23/2005US20050137190 Compositions useful as inhibitors of voltage-gated sodium channels
06/23/2005US20050137186 Tetrahydrobenzazepines and their use
06/23/2005CA2549548A1 Carboxamide derivatives
06/23/2005CA2549273A1 Novel m3 muscarinic acetylcholine receptor antagonists
06/23/2005CA2548426A1 Substituted piperazines
06/23/2005CA2548262A1 Method for the production of tetrahydrogeranylacetone
06/23/2005CA2547391A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
06/22/2005EP1544197A1 Intermediates for cephem compounds
06/22/2005EP1544194A1 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
06/22/2005EP1542993A1 Piperazine derivatives and methods of use
06/22/2005EP1542988A1 Piperidine quinolyl propyl derivatives, preparation method and intermediates and compositions containing same
06/22/2005EP1542980A1 5-aryltetrazole compounds, compositions thereof, and uses therefor
06/22/2005EP1542977A1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12.
06/22/2005EP1542976A1 Substituted 4-(indazol-3-yl)phenols as estrogen receptor (er) ligands and their use in the treatment of inflammatory diseases
06/22/2005EP1542973A1 2,4-substituted indoles and their use as 5-ht6 modulators
06/22/2005EP1542692A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain
06/22/2005EP1542667A2 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
06/22/2005EP1455787B1 Certain glycine derivatives as factor xa inhibitors for use in the treatment of thrombotic disorders
06/22/2005EP1100763B1 Diketoacid-derivatives as inhibitors of polymerases
06/22/2005CN1630654A R- - -1- [2- 7-chlorobenzo [b] thiophen-3 -yl- methoxy -2- 2, 4-dichlorophenyl -ethyl] -1h-imidazole
06/22/2005CN1630651A Novel gamma secretase inhibitors
06/22/2005CN1630645A 5-HT receptor ligands and uses thereof
06/22/2005CN1630644A Pyridine and pyrimidine derivatives
06/22/2005CN1630642A Benzenesulfonamide derivatives
06/22/2005CN1630637A Novel arylheteroalkylamine derivatives
06/22/2005CN1630517A CXCR4-antagonistic drugs composed of nitrogen-containing compound
06/22/2005CN1207288C Retroviral protease inhibiting compounds
1 ... 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 ... 523